Viewing Study NCT00717457


Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2026-01-01 @ 12:24 PM
Study NCT ID: NCT00717457
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2008-07-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module